Add as a preferred source on GoogleInjective Marks Canary Funds’ INJC ETF at Nasdaq Opening Bell
The Canary Funds product is the first U.S. ETF to track INJ. BitGo holds its spot tokens, and the fund plans to stake up to 90% of its holdings.
Injective marked Canary Funds' INJC exchange-traded fund at Nasdaq's opening bell, celebrating the listing of a U.S.-traded product that combines exposure to Injective (INJ) with staking.
INJC is the fund's ticker, not a separate crypto token. It is the first U.S. ETF to track INJ, and the fund's Nasdaq listing gives investors access to the product through a standard brokerage account.
BitGo holds the fund's spot INJ. The product plans to stake up to 90% of its holdings and automatically reinvest net staking proceeds.
Injective is a decentralized layer-1 blockchain designed for trading and decentralized finance applications.
Enna Lee
ReporterEnna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.